上消化道肿瘤VMAT放疗中气体体积变化的剂量学影响量化评估
该回顾性研究纳入8例胰腺癌患者,基于计划CT分别以气体密度覆盖值0.0、0.5、1.0生成3个参考计划,并利用锥形束CT(CBCT)计算分次剂量,评估腹部气体体积变化对容积旋转调强放疗(VMAT)剂量分布的影响。结果显示从CT到治疗CBCT气体体积平均减少48.6%,除肾脏外各靶区及危及器官累积剂量参数与Ref0.0计划偏差最小、与Ref1.0计划偏差最大,且PTV 95%剂量在Ref0.0与Ref1.0间差异有统计学意义。
要点
- 胰腺癌VMAT从CT到治疗CBCT气体体积平均减少48.6%。
- 除肾脏外,各剂量参数与Ref0.0计划偏差最小、与Ref1.0偏差最大。
- PTV 95%累积剂量在Ref0.0与Ref1.0间差异有统计学意义。
核心结论
- 胰腺癌VMAT全程气体体积可发生显著变化,初始计划以气体密度0.0评估对累积剂量预测最准确。
研究设计与样本
- 回顾性患者研究,纳入8例胰腺癌患者,基于计划CT以气体密度覆盖值0.0、0.5、1.0生成3个参考计划,并用CBCT计算分次剂量进行累积剂量比较。
主要发现
- 从CT到治疗CBCT气体体积平均减少48.6%。
- 除肾脏外,所有累积靶区及危及器官参数与Ref0.0计划平均偏差最小、与Ref1.0计划平均偏差最大。
- PTV 95%累积剂量在Ref0.0与Ref1.0间差异有统计学意义。
关键数值与推荐
- 参考计划气体密度覆盖值分别为0.0、0.5、1.0。
- 气体体积平均减少48.6%。
临床怎么用
- 胰腺癌VMAT计划评估时可优先参考气体密度覆盖值0.0的计划以预测累积剂量。
局限性
- 回顾性设计且样本量仅8例胰腺癌患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This retrospective patient study assessed the consistency of abdominal gas presence throughout radiation therapy for patients with upper gastrointestinal cancer and determined the impact of variations in gas volume on the calculated dose distribution of volumetric modulated arc therapy. METHODS AND MATERIALS: Eight patients with pancreatic cancer were included for analysis. A plan library consisting of 3 reference plans per patient (Ref0.0, Ref0.5, and Ref1.0) was created based on planning computed tomography (CT) with density overrides of 0.0, 0.5, and 1.0 applied to gas volumes, respectively. Corresponding cone beam CT (CBCT) data sets were obtained and density overrides were applied to enable fractional dose calculation. Variation in gas volume relative to initial volume determined from CT was assessed. Dose metrics for targets and organs at risk were compared between the accumulated CBCT dose and the planned dose of the 3 reference plans for each patient. RESULTS: There was a significant decrease in gas present from CT to treatment CBCT, with a mean decrease in volume of 48.6% for the entire cohort. Dosimetrically, all accumulated target and organ-at-risk parameters, aside from the kidneys, exhibited the smallest mean deviation from the Ref0.0 plan and largest mean deviation from the Ref1.0 plan. A statistically significant difference in mean accumulated dose to Ref0.0 and Ref1.0 was observed for the dose delivered to 95% of the planning target volume. CONCLUSIONS: Significant variation in gas volumes from CT to treatment can occur throughout volumetric modulated arc therapy for pancreatic cancer. Through the use of a plan library, it was determined that initial assessment of a patient's treatment plan with an assigned gas density of 0.0 provided the most accurate prediction of the accumulated dose.
引用
- Scott J, Dundas K, Surjan Y, et al. Quantifying and Assessing the Dosimetric Impact of Changing Gas Volumes Throughout the Course of VMAT Radiation Therapy of Upper Gastrointestinal Tumors. Adv Radiat Oncol. 2021. PMID: 34195488. doi:10.1016/j.adro.2021.100650
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。